article thumbnail

Governing Health Data for Research, Development, and Innovation: The Missteps of the European Health Data Space Proposal

Bill Of Health

By Enrique Santamaría Together with the Data Governance Act (DGA) and the General Data Protection Regulation (GDPR), the proposal for a Regulation on the European Health Data Space (EHDS) will most likely form the new regulatory and governance framework for the use of health data in the European Union. health data). If so, how?

article thumbnail

Petrie-Flom Welcomes 2022-2023 Student Fellows

Bill Of Health

After graduating from law school, she has trained at Hogan Lovells in their Milan office, specializing in pharmaceutical patent litigation. She has previously published articles on synthetic biology regulation and governance, end stage renal disease payment reform, and comparative analyses of learning disorder policy. Louis (USA).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

3 Lessons Learned from Pandemic-Era Clinical Development Regulatory Practices

HIT Consultant

In view of this, regulators have demonstrated unprecedented flexibility and collaboration with key industry players to support the delivery of treatments to the market. First, regulators liberally issued Emergency Use Authorizations (EUAs) for COVID-19 products to expedite the testing, treatment, and vaccination of patients.

article thumbnail

The Role of Intellectual Property in the Biopharmaceutical Sector

Healthcare ECONOMIST

 In the context of this fast-moving political debate, FTI Consulting supported INTERPAT, a non-profit biopharmaceutical consortium, and the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) in developing a White Paper and peer-reviewed article on the role of IP in the biopharmaceutical sector.

article thumbnail

Human Rights Principles in Public Health Emergencies: From the Siracusa Principles to COVID-19 and Beyond

Bill Of Health

From national disparities across populations, to global inequalities in access, to scarce medical technologies, from ventilators to vaccines, inequalities have been an overriding feature of this pandemic. Deep inequities and discrimination were manifested across the board.

article thumbnail

Reclaiming Global Public Health

Bill Of Health

New mRNA vaccines, underpinned by decades of public investment , had been authorized by global regulators. Dose shortages elevated the role of pharmaceutical executives. Pharmaceutical corporations hoarded technology that could have helped alleviate scarcity. Private decisions did not match public health need.

article thumbnail

Can the U.S. Improve Health System Performance with Digital Health Tools? Pondering A Big Question for #HIMSS21

Health Populi

That’s what government regulation and intervention are for, to make more fair and effective the lack of a real health care market. as well as the reduction in mitigation measures.” ” .